Morgan Stanley analyst Bob Huang maintained a Hold rating on Marsh & Mclennan Companies (MMC – Research Report) today and set a price
In a report released today, Nathan Race from Piper Sandler maintained a Hold rating on Commerce Bancshares (CBSH – Research Report), with a
Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 and touched a low of $126.
Morgan Stanley (NYSE:MS) adjusted its stance on Valvoline Inc . (NYSE:VVV), downgrading the stock from Overweight to Equalweight and lowering the price target to $38.00 from the previous $42.00. This move aligns with broader market sentiment,
European Wax Center Inc (EWCZ) stock saw a modest uptick, ending the day at $6.87 which represents a slight increase of $0.51 or 8.02% from the prior close of $6.36. The stock opened at $6.44 and touched a low of $6.
Morgan Stanley (NYSE:MS) upgraded OneStream Inc. (NASDAQ: OS) stock rating from Equalweight to Overweight, setting a new price target of $37.00. The upgrade aligns with broader analyst sentiment, as InvestingPro data shows a strong consensus recommendation of 1.
Piper Sandler reiterated their overweight rating on shares of Intuit (NASDAQ:INTU – Free Report) in a research report report published on Friday morning,Benzinga reports. They currently have a $765.00 target price on the software maker’s stock.
Charles Schwab (NYSE:SCHW – Get Free Report) had its price objective upped by research analysts at Morgan Stanley from $74.00 to $84.00 in a research report issued to clients and investors on Friday.
Wingstop (NASDAQ:WING – Get Free Report) was upgraded by research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research report issued to clients and investors on Tuesday,
HB Wealth Management LLC cut its holdings in Carvana Co. (NYSE:CVNA – Free Report) by 5.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 2,703 shares of the company’s stock after selling 162 shares during the period.
Kenneth Robert Bertram, Chief Legal Officer and Secretary of CAVA Group, Inc. (NYSE:CAVA), recently sold shares of the company's common stock valued at approximately $114,170. The transactions, which occurred on January 21,
Adam J. Townsend, Chief Commercial Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.87 billion market cap biotech company, recently sold 3,323 shares of the company's common stock. The transaction,